Press release

DSM finalizes sale of DSM Synres to Standard Investment

Heerlen, NL, 02 Apr 2015 08:16 CEST

Royal DSM, the global Life Sciences and Materials Sciences company, today announces it has finalized the sale of DSM Synres to Standard Investment. The divestment was announced on 17 December 2014.

DSM Synres produces solvent-borne alkyd and acrylic coating resins at its site in Hoek van Holland (Netherlands) for the global coatings, adhesives and graphic arts markets since 1947. DSM Synres realizes sales of approximately €50 million with around 80 employees.

Standard Investment, based in Amsterdam, is a hands-on private equity firm focused on small and medium-sized enterprises in the Netherlands and Belgium. Since its establishment in 2004, the firm has acquired a portfolio of 18 companies.

For more information

Lieke de Jong-Tops

Senior Communications Manager
+31 45 578 2420

Dave Huizing

Vice President Investor Relations
+31 45 578 2864

Media Relations

+31 45 578 2420

Investor Relations

+31 45 578 2864

Use of cookies

We would like to use cookies to detect our users’ preferences and design the website optimally. More detailed information and instructions on how you can revoke your consent at any time are provided in our Data Privacy Declaration.

Read more